The Early Achievement of Measurable Residual Disease Negativity in the Treatment of Adults with Philadelphia-Negative B-Cell Acute Lymphoblastic Leukemia is a Strong Predictor for Survival

被引：0

作者：

Yilmaz, Musa ^{[1
]}

Kantarjian, Hagop ^{[1
]}

Wang, Xuemei ^{[2
]}

Loghavi, Sanam ^{[3
]}

Khoury, Joseph ^{[3
]}

Jorgensen, Jeffrey ^{[3
]}

Ravandi, Farhad ^{[1
]}

Short, Nicholas ^{[1
]}

Cortes, Jorge ^{[1
]}

Garcia-Manero, Guillermo ^{[1
]}

Kadia, Tapan ^{[1
]}

Sasaki, Koji ^{[1
]}

Konopleva, Marina ^{[1
]}

Takahashi, Koichi ^{[1
]}

Wierda, William ^{[1
]}

Khouri, Maria ^{[1
]}

Jain, Nitin ^{[1
]}

Verstovsek, Srdan ^{[1
]}

Estrov, Zeev ^{[1
]}

Bose, Prithviraj ^{[1
]}

Pierce, Sherry ^{[1
]}

Garris, Rebecca ^{[1
]}

O'Brien, Susan ^{[4
]}

Jabbour, Elias ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA

[3] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA

[4] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Orange, CA 92668 USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷

关键词：

minimal residual disease; ALL; survival; early; acute lymphoblastic leukemia;

D O I：

10.1016/j.clml.2019.07.040

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

ALL-280

引用

页码：S193 / S194

页数：2

共 50 条

[41] Measurable residual disease testing by next generation sequencing is more accurate compared with multiparameter flow cytometry in adults with B-cell acute lymphoblastic leukemia
Yana, Nan
Wang, Zi-Long
Wang, Xiao-Juan
Gale, Robert Peter
Zhou, Ya-Lan
Zhao, Ming-Yue
Wu, Li-Xin
Liao, Ming-Yue
Yang, Jie
Wang, Chun-Yang
Zhu, Jian-Hua
Jiang, Hao
Jiang, Qian
Liu, Yan-Rong
Chang, Ying-Jun
Xu, Lan-Ping
Zhang, Xiao-Hui
Ma, Tong-Hui
Huang, Xiao-Jun
Ruan, Guo-Rui
CANCER LETTERS, 2024, 598
[42] ZNF384 fusion transcript levels for measurable residual disease monitoring in adult B-cell acute lymphoblastic leukemia
Shi, Zong-Yan
Wang, Xu
Chen, Wen-Min
Li, Ling-Di
Hao, Yue
Li, Jin-Ying
Sun, Kai
Zhao, Xiao-Su
Jiang, Hao
Jiang, Qian
Huang, Xiao-Jun
Qin, Ya-Zhen
HEMATOLOGICAL ONCOLOGY, 2024, 42 (01)
[43] Clearance of Very Low Levels of Measurable Residual Disease with Blinatumomab Significantly Improves Outcomes in B-Cell Acute Lymphoblastic Leukemia
Nguyen, Daniel
Jabbour, Elias
Jain, Nitin
Karrar, Omer
Nasnas, Cedric
Haddad, Fadi G.
Senapati, Jayastu
Kadia, Tapan M.
Garris, Rebecca
Kantarjian, Hagop M.
Short, Nicholas J.
BLOOD, 2024, 144 : 1465 - 1466
[44] Clinical significance of end of induction measurable residual disease monitoring in B-cell acute lymphoblastic leukemia: A single center experience
Arunachalam, Arun Kumar
Selvarajan, Sushil
Mani, Thenmozhi
Janet, Nancy Beryl
Maddali, Madhavi
Lionel, Sharon Anbumalar
Kulkarni, Uday
Korula, Anu
Aboobacker, Fouzia N.
Abraham, Aby
George, Biju
Balasubramanian, Poonkuzhali
Mathews, Vikram
CYTOMETRY PART B-CLINICAL CYTOMETRY, 2023, 104 (06) : 440 - 452
[45] Increased Incidence of Philadelphia Negative B-Cell Acute Lymphoblastic Leukemia Among Adults of Hispanic Ethnicity: A Population Based Study
Perry, Ashley M.
Chen, Evan C.
Jalbut, Marla M.
Werner, Lillian
Hobbs, Gabriela S.
Amrein, Philip C.
Fathi, Amir T.
Brunner, Andrew M.
BLOOD, 2017, 130
[46] PROGNOSTIC IMPACT OF CD20 EXPRESSION IN ADULTS WITH PHILADELPHIA CHROMOSOME NEGATIVE PRECURSOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Djunic, I.
Virijevic, M.
Kraguljac-Kurtovic, N.
Knezevic, V.
Dragovic-Ivancevic, T.
Novkovic, A.
Mitrovic, M.
Colovic, N.
Vidovic, A.
Suvajdzic-Vukovic, N.
Tomin, D.
HAEMATOLOGICA, 2016, 101 : 660 - 661
[47] Augmented Berlin-Frankfurt-Munster versus GRAALL-2003 in young adults with Philadelphia-negative, B-cell acute lymphoblastic leukemia: A single-center experience
Ghobrial, Fady E., I
Elkerdawy, Heidi
Abdelhakiem, Mostafa
El-Ashwah, Shaimaa
EGYPTIAN JOURNAL OF HAEMATOLOGY, 2022, 47 (04): : 281 - 287
[48] Curative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic leukemia
Goekbuget, Nicola
Zugmaier, Gerhard
Dombret, Herve
Stein, Anthony
Bonifacio, Massimiliano
Graux, Carlos
Faul, Christoph
Brueggemann, Monika
Taylor, Kate
Mergen, Noemi
Reichle, Albrecht
Horst, Heinz-August
Havelange, Violaine
Topp, Max S.
Bargou, Ralf C.
LEUKEMIA & LYMPHOMA, 2020, 61 (11) : 2665 - 2673
[49] RAS pathway mutation is an added-value biomarker in pediatric Philadelphia-negative B-cell acute lymphoblastic leukemia with IKZF1 deletions
Huang, Ying-Jung
Liu, Hsi-Che
Jaing, Tang-Her
Wu, Kang-Hsi
Wang, Shih-Chung
Yen, Hsiu-Ju
Hsiao, Chih-Cheng
Chen, Shih-Hsiang
Lin, Pei-Chin
Yeh, Ting-Chi
Sheen, Jiunn-Ming
Chen, Yu-Chieh
Chang, Te-Kau
Huang, Fang-Liang
Chao, Yu-Hua
Hou, Jen-Yin
Yang, Chao-Ping
Lin, Tung-Huei
Shih, Lee-Yung
PEDIATRIC BLOOD & CANCER, 2021, 68 (04)
[50] Phase II Study of Blinatumomab in Patients with B-Cell Acute Lymphoblastic Leukemia (B-ALL) with Positive Measurable Residual Disease (MRD)
Richard-Carpentier, Guillaume
Kantarjian, Hagop M.
Jorgensen, Jeffrey L.
Wang, Sa A.
Khoury, Joseph D.
Ravandi, Farhad
Short, Nicholas J.
Khouri, Rita
Takahashi, Koichi
Ohanian, Maro
Borthakur, Gautam M.
Konopleva, Marina Y.
Daver, Naval G.
Estrov, Zeev E.
Alvarado, Yesid
Jain, Nitin
Kadia, Tapan M.
Garcia-Manero, Guillermo
Velasquez, Michelle
Nasnas, Patrice
O'Brien, Susan
Jabbour, Elias
BLOOD, 2019, 134

← 1 2 3 4 5 →